CLVS
Wolverine Trading’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-45,133
| Closed | -$77K | – | 2556 |
|
|
2022
Q2 | $77K | Buy |
+45,133
| New | +$77K | ﹤0.01% | 1013 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 2914 |
|
|
2021
Q4 | – | Sell |
-28,367
| Closed | -$128K | – | 3004 |
|
|
2021
Q3 | $128K | Buy |
28,367
+6,528
| +30% | +$29.5K | ﹤0.01% | 1695 |
|
|
2021
Q2 | $128K | Buy |
21,839
+7,679
| +54% | +$45K | ﹤0.01% | 1581 |
|
|
2021
Q1 | $96K | Sell |
14,160
-7,805
| -36% | -$52.9K | ﹤0.01% | 1635 |
|
|
2020
Q4 | $108K | Sell |
21,965
-1,297
| -6% | -$6.38K | ﹤0.01% | 1332 |
|
|
2020
Q3 | $138K | Buy |
+23,262
| New | +$138K | ﹤0.01% | 1073 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 2238 |
|
|
2019
Q4 | – | Sell |
-17,702
| Closed | -$71K | – | 2175 |
|
|
2019
Q3 | $71K | Buy |
17,702
+3,977
| +29% | +$16K | ﹤0.01% | 1174 |
|
|
2019
Q2 | $204K | Buy |
13,725
+5,230
| +62% | +$77.7K | ﹤0.01% | 962 |
|
|
2019
Q1 | $211K | Sell |
8,495
-25,495
| -75% | -$633K | ﹤0.01% | 954 |
|
|
2018
Q4 | $611K | Buy |
+33,990
| New | +$611K | ﹤0.01% | 572 |
|
|
2018
Q3 | – | Sell |
-11,608
| Closed | -$613K | – | 2466 |
|
|
2018
Q2 | $613K | Hold |
11,608
| – | – | ﹤0.01% | 615 |
|
|
2018
Q1 | $613K | Sell |
11,608
-31,340
| -73% | -$1.66M | ﹤0.01% | 615 |
|
|
2017
Q4 | $2.92M | Sell |
42,948
-30,292
| -41% | -$2.06M | 0.01% | 238 |
|
|
2017
Q3 | $6.04M | Buy |
73,240
+932
| +1% | +$76.8K | 0.02% | 65 |
|
|
2017
Q2 | $6.65M | Buy |
72,308
+38,197
| +112% | +$3.51M | 0.03% | 50 |
|
|
2017
Q1 | $2.14M | Buy |
+34,111
| New | +$2.14M | 0.01% | 174 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 2238 |
|
|
2016
Q3 | – | Sell |
-15,957
| Closed | -$240K | – | 2178 |
|
|
2016
Q2 | $240K | Buy |
+15,957
| New | +$240K | ﹤0.01% | 625 |
|